Intraoperative ultrasound: Improved resection rates in breast-conserving surgery

Anticancer Research

Volumn 32, Issue 3, 2012, Pages 1051-1056

  Eichler, Christian ^a   Hübbel, Annette ^b   Zarghooni, Verena ^a   Thomas, Anke ^c   Gluz, Oleg ^d   Stoff Khalili, Mariam ^a   Warm, Mathias ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b Johanniter Krankenhaus   (Germany)

^c HUMBOLDT UNIVERSITY   (Germany)

^d Bathesda Clinics   (Germany)

Author keywords

Breast cancer; Breast conserving surgery; Resection rate improvement; Sonography; Ultrasound

Indexed keywords

CYCLOPHOSPHAMIDE; DOCETAXEL; EPIRUBICIN; LETROZOLE;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CANCER SURGERY; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; PEROPERATIVE ECHOGRAPHY; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

BREAST NEOPLASMS; FEMALE; HUMANS; INTRAOPERATIVE CARE; MASTECTOMY; RETROSPECTIVE STUDIES;

EID: 84858779838     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Ohlinger R, Heyer H, Thomas A, Paepke S, Warm H and Klug U: Non-palpable breast lesions in asymptomatic women: diagnostic value of initial ultrasonography and comparison with mammography. Anticancer Res 26(5B): 3943-3955, 2006. (Pubitemid 44701482)
2. Rahbar G, Sie AC, Hansen GC, Prince JS, Melany ML and Reynolds HE: Benign versus malignant solid breast masses: US differentiation. Radiology 213(3): 889-894, 1999.
3. Weismann C and Hergan K: Current status of 3D/4D volume ultrasound of the breast. Ultraschall Med 28(3): 273-282, 2007, (in German). (Pubitemid 47047585)
4. Kuerer HM, Singletary SE, Buzdar AU, Ames FC, Valero V and Buchholz TA: Surgical conservation planning after neoadjuvant chemotherapy for stage II and operable stage III breast carcinoma. Am J Surg 182(6): 601-608, 2001. (Pubitemid 34142679)
5. Thomas A, Ohlinger R, Hauschild M, Mustea A, Blohmer JU and Kummel S: Options and limits of surgery after pre-operative chemotherapy in breast cancer. Anticancer Res 26(2C): 1677-1682, 2006.
6. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M and Fisher ER: Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347(16): 1233-1241, 2002. (Pubitemid 35176242)
7. Fisher B, Jeong JH, Anderson S, Bryant J, Fisher ER and Wolmark N: Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med 347(8): 567-575, 2002.
8. van Dongen JA, Voogd AC, Fentiman IS, Legrand C, Sylvester RJ and Tong D: Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst 92(14): 1143-1150, 2000.
9. Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R and Luini A: Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347(16): 1227-1232, 2002. (Pubitemid 35176241)
10. Fuchs R, Guggenberger D and Karl C: Mammakarzinom - Diagnostik und Therapie, Eschweiler: Euregio-Brust-Zentrum, Germany 2001/2005. (in German)
11. Guidelines of the German Association for OB/GYN - Interdisziplinäre S3-Leitlinie für die Diagnostik, Therapie und Nachsorge des Mammakarzinoms 2008. (in German)
12. Olsha O, Shemesh D, Carmon M, Sibirsky O, Abu Dalo R and Rivkin L: Resection margins in ultrasound-guided breast-conserving surgery. Ann Surg Oncol 18(2): 447-452, 2011.
13. Strnad P. The 5th edition of the TNM classification - malignant tumors of the breast. Ceska Gynekol 64(1): 54-57, 1999.